Alzamend Neuro, Inc. (ALZN)
1.92
-0.05
(-2.54%)
USD |
NASDAQ |
Feb 10, 16:00
1.94
+0.02
(+1.04%)
After-Hours: 20:00
Alzamend Neuro EPS Diluted (Quarterly) : -0.296 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 4.67 |
| Allogene Therapeutics, Inc. | -0.1864 |
| Embecta Corp. | 0.7438 |
| BrightSpring Health Services, Inc. | 0.2562 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.001M |
| Total Expenses (Quarterly) | 1.001M |
| Enterprise Value | 1.579M |
| Earnings Yield | -286.2% |
| Normalized Earnings Yield | -286.24 |